926 - 950 of 8825 Results
Title
Year
- Initiation of antidepressant medication and risk of incident stroke: using the Adult Changes in Thought cohort to address time-varying confounding2019RESTRICTEDTitle: Initiation of antidepressant medication and risk of incident stroke: using the Adult Changes in Thought cohort to address time-varying confoundingJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 0
- Parkinson’s disease genetics: identifying novel risk loci, providing causal insights and improving estimates of heritable risk2018RESTRICTEDTitle: Parkinson’s disease genetics: identifying novel risk loci, providing causal insights and improving estimates of heritable riskJournal Name:Publisher:Vol:Issue #:Start Page: 388165End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 4
- Automatic Scoring of Parkinson’s Disease Motor Symptoms Using a Smartwatch (P2.8-001)2019RESTRICTEDTitle: Automatic Scoring of Parkinson’s Disease Motor Symptoms Using a Smartwatch (P2.8-001)Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 0
- Finding useful biomarkers for Parkinson's disease2018RESTRICTEDTitle: Finding useful biomarkers for Parkinson's diseaseJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 0
- The BioFIND Study (Fox Investigation For New Discovery Of Biomarkers In Parkinson’s Disease): Design And Methodology (P4.043)2014RESTRICTEDTitle: The BioFIND Study (Fox Investigation For New Discovery Of Biomarkers In Parkinson’s Disease): Design And Methodology (P4.043)Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 2
- Clinician-Input Study (CIS-PD): how the Fox Wearable Companion Application can influence treatment and care in Parkinson’s disease (P3.048)2018RESTRICTEDTitle: Clinician-Input Study (CIS-PD): how the Fox Wearable Companion Application can influence treatment and care in Parkinson’s disease (P3.048)Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 0
- Fox Insight: a Large-Scale Web-Enabled Parkinson’s Disease Study (P4.007)2017RESTRICTEDTitle: Fox Insight: a Large-Scale Web-Enabled Parkinson’s Disease Study (P4.007)Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 0
- Combined Fenobam and Amantadine Signigficantly Reduce Levodopa-Induced Dyskinesia in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson’s Disease (P1.016)2014RESTRICTEDTitle: Combined Fenobam and Amantadine Signigficantly Reduce Levodopa-Induced Dyskinesia in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson’s Disease (P1.016)Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 0
- Assessing Tele-Health Outcomes in Multiyear Extensions of Parkinson’s Disease Trials (AT-HOME PD): Initiation of a Long-Term Observational Study (P2.8-011)2019RESTRICTEDTitle: Assessing Tele-Health Outcomes in Multiyear Extensions of Parkinson’s Disease Trials (AT-HOME PD): Initiation of a Long-Term Observational Study (P2.8-011)Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 0
- Validation of Fox Insight Cohort via Virtual Research Visits (4749)2020RESTRICTEDTitle: Validation of Fox Insight Cohort via Virtual Research Visits (4749)Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 0
- Endogenous Rab29 does not impact basal or nigericin and monensin stimulated LRRK2 pathway activity2020RESTRICTEDTitle: Endogenous Rab29 does not impact basal or nigericin and monensin stimulated LRRK2 pathway activityJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 1
- Novel therapeutic approaches to target neurodegeneration2022RESTRICTEDTitle: Novel therapeutic approaches to target neurodegenerationJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.22541/au.167164898.84768756Citation Count: 0
- Ethical and Responsible Use of AI/ML in the Earth, Space, and Environmental Sciences2023RESTRICTEDTitle: Ethical and Responsible Use of AI/ML in the Earth, Space, and Environmental SciencesJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.22541/essoar.168132856.66485758Citation Count: 1
- Journal Production Guidance for Software and Data Citations2022RESTRICTEDTitle: Journal Production Guidance for Software and Data CitationsJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.22541/essoar.167252601.17695321Citation Count: 0
- Automatic Facial Landmark Localization in Clinical Populations - Improving Model Performance with a Small Dataset2020RESTRICTEDTitle: Automatic Facial Landmark Localization in Clinical Populations - Improving Model Performance with a Small DatasetJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.21203/rs.3.rs-19405Citation Count: 3
- Neurochemical biomarkers in the differential diagnosis of movement disorders2009RESTRICTEDTitle: Neurochemical biomarkers in the differential diagnosis of movement disordersJournal Name: Movement DisordersPublisher: WileyVol: 24Issue #: 10Start Page: 1411End Page: 1426Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22510Citation Count: 43
- Aptamers targeting amyloidogenic proteins and their emerging role in neurodegenerative diseases2022RESTRICTEDTitle: Aptamers targeting amyloidogenic proteins and their emerging role in neurodegenerative diseasesJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 298Issue #: 1Start Page: 101478End Page: 101478Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jbc.2021.101478Best OA location URL: http://www.jbc.org/article/S0021925821012874/pdfCitation Count: 19
-
RESTRICTEDTitle: Involvement of dopaminergic signaling in the cross talk between the renin-angiotensin system and inflammationJournal Name: Seminars in ImmunopathologyPublisher: Springer Science and Business Media LLCVol: 42Issue #: 6Start Page: 681End Page: 696Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00281-020-00819-8Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00281-020-00819-8.pdfCitation Count: 10
-
RESTRICTEDTitle: Inflammation in Experimental Models of α‐SynucleinopathiesJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 37End Page: 49Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28264Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115204Citation Count: 24
- Discovery of the First Selective M4 Muscarinic Acetylcholine Receptor Antagonists with in Vivo Antiparkinsonian and Antidystonic Efficacy2021RESTRICTEDTitle: Discovery of the First Selective M4 Muscarinic Acetylcholine Receptor Antagonists with in Vivo Antiparkinsonian and Antidystonic EfficacyJournal Name:Publisher:Vol:Issue #:Start Page: 1306End Page: 1321Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acsptsci.0c00162;Citation Count: 9
-
RESTRICTEDTitle: Application of deep learning in detecting neurological disorders from magnetic resonance images: a survey on the detection of Alzheimer’s disease, Parkinson’s disease and schizophreniaJournal Name: Brain InformaticsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40708-020-00112-2Best OA location URL: https://braininformatics.springeropen.com/track/pdf/10.1186/s40708-020-00112-2Citation Count: 182
- Commentary: Atypical, Early‐Onset Dystonia‐Parkinsonism with Oculogyric Crises and Anterior Horn Cell Disorder due to a Novel DJ ‐1 Mutation2021RESTRICTEDTitle: Commentary: Atypical, Early‐Onset Dystonia‐Parkinsonism with Oculogyric Crises and Anterior Horn Cell Disorder due to a Novel DJ ‐1 MutationJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13296;Citation Count: 1
- High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s disease2021RESTRICTEDTitle: High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s diseaseJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1186/s40478-021-01282-8;Citation Count: 68
- Mitochondrial isolation: when size matters2020RESTRICTEDTitle: Mitochondrial isolation: when size mattersJournal Name:Publisher:Vol:Issue #:Start Page: 226End Page: 226Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.12688/wellcomeopenres.16300.1;Citation Count: 3
- Measuring the Impact of Patient Engagement and Patient Centricity in Clinical Research and Development2019RESTRICTEDTitle: Measuring the Impact of Patient Engagement and Patient Centricity in Clinical Research and DevelopmentJournal Name:Publisher:Vol:Issue #:Start Page: 216847901881751End Page: 216847901881751Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/2168479018817517;Citation Count: 21